# aTYR PHARMA INC: Form 8-K, filed May 9, 2023

- Company: [aTYR PHARMA INC](/companies/atyr.md) (CIK 1339970)
- Form: 8-K
- Filed: 2023-05-09
- Accepted by EDGAR: May 9, 2023, 16:07 ET
- Period: 2023-05-09
- Accession: 0000950170-23-019633
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1339970/000095017023019633/life-20230509.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1339970/000095017023019633/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1339970/000095017023019633/life-20230509.htm

Filed May 9, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-019633. Last ingested by Listed: Oct 27, 2026, 09:04 ET. No prices; not investment advice.